Most people hear “$1,000 a month” and stop listening. It is the number that comes up when you Google Zepbound, and it is technically accurate. It is also almost never what Texas patients pay. Once you understand the savings programs available right now, the real cost looks very different depending on your insurance situation.
This guide breaks down every legitimate way to reduce your Zepbound cost in 2026, who qualifies for each one, and what changed from last year. If you read anything about the savings card before 2026, the caps and fill limits have been updated. Check the current numbers below.
The Zepbound savings card is a free copay program from Eli Lilly. It does not replace your insurance. It sits on top of it. You enroll at zepbound.lilly.com/savings, pick up a digital card with a BIN, PCN, and Group number, and hand those numbers to the pharmacist when you fill your prescription.
Here is where most people run into trouble: the card has to be activated before your first fill. Not after. Not the same day at the pharmacy counter. Before. If you walk in with a prescription and an unactivated card, you pay full list price for that fill, and the card cannot be applied retroactively. The enrollment itself takes about two minutes online. Do it before you need it.
For 2026, the covered-benefit version of the card brings your copay down to as little as $25 per fill when your commercial insurance covers Zepbound. The maximum the card will cover is $100 per one-month fill, $200 for a two-month fill, or $300 for a three-month supply. The annual savings cap is $1,300, valid for up to 13 fills, and the card expires December 31, 2026.
The savings card is for people with commercial or private insurance, which means coverage through an employer or a marketplace plan. U.S. and Puerto Rico residents only.
If you have Medicare, Medicaid, Tricare, VA benefits, or any other government-funded insurance, the card is not available to you. This is not a Lilly policy choice. Federal law prohibits manufacturer copay programs from being combined with government insurance across the pharmaceutical industry. There is movement on this front for Medicare patients specifically, and that is covered in the Medicare section below.
If your commercial insurance covers Zepbound, the covered-benefit card is your best option. If your plan does not cover it, a separate non-covered benefit version applies. That version saves up to $469 per month, caps at $3,283 annually, and allows up to 7 fills per calendar year.
| Ready to talk through your weight loss options with a licensed Texas provider?Book my medical weight loss consultation at InjectCo | Call us: Fort Worth (817) 285-5254 | Plano (972) 430-9297 |
Your cost comes down to one question: what does your insurance do with Zepbound? Everything follows from there.
| Your Situation | Savings Card Version | What You Pay Per Month |
| Commercial insurance covers Zepbound | Covered benefit | As low as $25 per fill |
| Commercial insurance, Zepbound not covered | Non-covered benefit | Approx. $499 (up to $469 off list price) |
| No insurance at all (self-pay) | Self-pay card via LillyDirect | $299 to $449 depending on dose |
| Medicare, Medicaid, or a government plan | Not available — federal law | See Medicare section below |
One thing worth knowing about the covered benefit version: the $25 floor applies when your post-insurance copay exceeds $25. If your plan already brings your copay below that, the savings card covers whatever is left. The $1,300 annual cap resets each January 1.
For patients without insurance or patients whose plans do not include Zepbound on the formulary, LillyDirect is Eli Lilly’s direct-to-consumer option. The pricing as of 2026: $299 per month for the 2.5 mg starting dose, $449 per month for the 7.5 mg through 15 mg maintenance doses. No insurance is involved.
The program includes a telehealth consultation through a partnered clinician and delivers medication to your home. It is a legitimate, accessible path to the medication for patients who would otherwise face the list price.
The detail most people miss is the 45-day refill window. If you go more than 45 days without refilling from your previous delivery, you lose the discounted rate for that fill and have to restart at the list price. Set a calendar reminder. It is a small step that saves a significant amount of money.
This is the first question patients ask, and the honest answer is: it depends on your specific plan, not just your insurance company. Coverage is decided at the plan level. Two people with the same insurer can have completely different Zepbound coverage depending on which plan they are enrolled in.
That said, here is what patient experience in Texas currently shows across the major insurers:
If your plan denies coverage, the first step is having your provider submit a prior authorization with supporting clinical documentation.
A denial on the first round is not a final answer. Many first-round denials are overturned on appeal when the paperwork goes in with thorough clinical support.
One of our providers at our Fort Worth location worked through exactly this with a patient earlier this year. The plan was denied on the first round. Prior authorization went in with additional documentation. Coverage was approved within a week, and the savings card was activated that same afternoon.
As of June 2026, Zepbound is not covered by the Lilly Cares Patient Assistance Program. Lilly Cares does cover Mounjaro, which uses the same active ingredient for type 2 diabetes, but the weight loss indication is excluded. Check lillycareshelp.com for any updates.
Two third-party programs are worth knowing about:
One more thing worth asking your prescribing provider: Pharmaceutical representatives sometimes leave medication samples. It is not guaranteed and availability shifts regularly, but it is a reasonable question to raise at your first consultation.
Medicare patients have had no access to the savings card and very limited coverage for GLP-1 weight loss medications. That is starting to shift.
In November 2025, Eli Lilly and the U.S. government announced an agreement that would allow Medicare beneficiaries to access Zepbound for obesity at approximately $50 per month through a new GLP-1 Bridge program. The program is targeting a mid-2026 launch.
A few specifics worth knowing: the program covers the Zepbound KwikPen for obesity. Vials are not included. Patients already receiving Medicare coverage for Zepbound for obstructive sleep apnea are not eligible for the Bridge program.
Texas Medicaid does not currently provide broad coverage for Zepbound for weight loss. Some state programs are expanding access in 2026, but Medicaid patients in Texas should verify current formulary status directly with their pharmacy or provider before assuming coverage is in place.
The list price on Zepbound is not the price most people pay. Between the savings card, LillyDirect, the coming Medicare Bridge program, and the appeal process for insurance denials, there are real options for most patients in Texas, regardless of their insurance situation.
What makes the most difference, practically speaking, is knowing which path applies to you before you arrive at the pharmacy counter. The covered-benefit savings card needs to be activated before your first fill. LillyDirect requires enrollment through a telehealth consult. The non-covered benefit card involves different caps and fill limits than the covered version. Getting this sorted ahead of time is the difference between paying $25 and paying $1,000 for the same prescription.
At InjectCo, our licensed providers across nine Texas locations approach weight loss as a clinical program, with medication as one possible component based on what is appropriate for each patient. Our team works through savings card eligibility, prior authorization, and LillyDirect enrollment with patients every week. If you want to understand your specific situation before committing to anything, a telehealth consultation is a good starting point. Our providers in Dallas-Fort Worth, Plano, Colleyville, the Woodlands, and surrounding areas are available in-clinic and via telehealth.
Schedule your medical weight loss consultation at InjectCo, or call us: Fort Worth (817) 285-5254 | Plano (972) 430-9297.
A: It is a free copay program from Eli Lilly. Enroll at zepbound.lilly.com/savings before your first fill, present your BIN number at the pharmacy, and pay as little as $25 per fill if your commercial insurance covers Zepbound. It works alongside your existing plan and expires December 31, 2026.
A: Without insurance and without a savings program, the Eli Lilly list price is approximately $1,059 to $1,086 per month, depending on dose. Most patients do not pay this. Uninsured patients can use LillyDirect at $299 per month for the starting dose or $449 per month for maintenance doses. The self-pay savings card via LillyDirect is a separate program from the commercial insurance version.
A: BCBS of Texas coverage varies by plan. Many commercial BCBS plans cover Zepbound for obesity when BMI criteria are met, and prior authorization is submitted. Coverage is determined at the plan level, not the insurer level. Check your specific plan’s formulary or call the member services number on your card to confirm.
A: Some UnitedHealthcare plans cover Zepbound with prior authorization and documented medical necessity for obesity or a weight-related condition. Not all UHC plans include it. Your prescribing provider needs to submit prior authorization with clinical documentation. If denied, an appeal with additional documentation overturns many first-round denials.
A: Yes, under a different version. The non-covered benefit savings card applies when your commercial insurance does not include Zepbound on its formulary. It saves up to $469 per month with an annual cap of $3,283 and can be used for up to 7 fills per year. If you have no insurance at all, use LillyDirect’s self-pay program instead.
A: No. Federal law prohibits manufacturer copay cards from being used with Medicare, Medicaid, Tricare, VA benefits, or any government-funded insurance. However, a Medicare GLP-1 Bridge program is targeting a mid-2026 launch and would bring Zepbound KwikPen costs to approximately $50 per month for eligible Medicare beneficiaries with obesity.
As of June 2026, Lilly Cares does not cover Zepbound for weight loss. It covers Mounjaro for type 2 diabetes, but not Zepbound for weight management. For low-income patients, the Patient Advocate Foundation Co-Pay Relief Obesity Program may offer copay assistance for qualifying patients at or below 500% of the Federal Poverty Level. Check copays.org for current fund availability.
A: The 2026 covered-benefit card caps savings at $1,300 per calendar year, up to $100 per one-month fill. The non-covered benefit version caps at $3,283 per year, up to $469 per month. Both cards expire December 31, 2026 and are renewed annually by Lilly with updated terms.
A: Go to zepbound.lilly.com/savings and complete the enrollment form. It takes about two minutes. Enter your insurance details, download your digital savings card, and save the BIN, PCN, and Group numbers. Present those numbers at the pharmacy when filling your prescription. Enrollment must be completed before your first fill.
A: If you have commercial insurance that covers Zepbound, the savings card may bring your cost down to $25 per fill, making it the lowest-cost option for many eligible patients. Without insurance, LillyDirect at $299 per month for the starting dose is currently one of the lowest legitimate self-pay options for brand-name Zepbound. A licensed InjectCo provider can help you understand which option may apply to your situation and whether prior authorization is worth pursuing through your insurance.
| Written by: Kiara DeWitt, BSN, RN, CPN Kiara DeWitt, BSN, RN, CPN is the founder of InjectCo MedSpa and a former lead clinical educator in the neurosurgery and neurology unit at Cook Children’s Pediatric Hospital. She earned her nursing degree from Texas Christian University and has performed thousands of aesthetic treatments across InjectCo’s 9 Texas locations. She founded the Texas Academy of Medical Aesthetics to raise the standard of nurse-led aesthetic care statewide. |
| Medical Disclaimer The information in this article is for educational purposes only and does not constitute medical advice. Results vary by individual. Always consult a licensed healthcare provider before beginning any medical treatment or weight loss program. Savings program terms are accurate as of June 2026 and subject to change by the manufacturer. Verify current program eligibility at zepbound.lilly.com/savings. |
